CompletedNot Applicable

Evaluation of Predictive Factors for Right Ventriculaire Dysfunction

France18 participantsStarted 2021-04-09

Plain-language summary

An observational study of patients in cardiogenic shock under veno-arterial ECMO is designed to describe the clinical, ultrasound and hemodynamic parameters of these patients and to establish a predictive score for right-sided dysfunction in a patient within 48 hours of ECMO withdrawal after placement of IMPELLA®.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. \- Patient over 18 years of age
✓. \- Patient under ECMO hospitalized in the medical intensive care unit or the surgical intensive care unit of the Groupement hospitalier Pitié-Salpêtrière, not weaned from ECMO, in whom it was decided at the multidisciplinary collegial meeting on assistance-transplantation to set up an IMPELLA before the implantation of left monoventricular assistance.
✓. \- Patient who received informed information about the study and did not express opposition to participation in the research.
✓. \- Patient affiliated or entitled to a French social security system -

Exclusion criteria

✕. \- SAPS-II Score \> 90 (Simplified Acute Physiology Score (SAPS-II) at Inclusion
✕. \- Subject deprived of liberty by judicial decision
✕. \- Pregnant or breastfeeding woman

What they're measuring

Absence of right heart failure or failure to withdraw ECMO due to right heart failure after placement of IMPELLA®.

Timeframe: Within 48 hours of ECMO withdrawal after placement of IMPELLA®

Trial details

NCT IDNCT04596982

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-25

View on ClinicalTrials.gov More Right Ventriculaire Dysfunction trials